ClinicalTrials.Veeva

Menu

Self- Administered Acupressure for Diarrhea Predominant Irritable Bowel Syndrome

A

Alexandria University

Status

Completed

Conditions

Irritable Bowel Syndrome With Diarrhea

Treatments

Other: Active acupressure
Other: Sham acuptressure

Study type

Interventional

Funder types

Other

Identifiers

NCT05702255
2022-9-55

Details and patient eligibility

About

This study aims to assess the effect of active self- administered acupressure compared to sham self- administered acupressure on the health outcome for patient with diarrhea predominant Irritable Bowel Syndrome

Full description

Research suggests promising benefits of acupuncture in terms of symptom control and quality of life improvements in patients with irritable bowel syndrome. but the cost of the needle and the invasive nature of the procedure decreases patient compliance with acupuncture. in this respect, acupressure can be taught to patients to allow them to perform it themselves, instead of being administered by practitioners. Self-administered acupressure is less time-intensive, low-cost, and flexible to perform. Nurses involved in irritable bowel syndrome patient care play an active role in the practitioner-patient relationship By assessing the specific symptoms that are present, determining the severity of symptoms and the impact on the irritable bowel syndrome patient's life, and being knowledgeable of available treatment options, the nurse involved in irritable bowel syndrome care becomes an essential conduit of information and a valuable facilitator of a positive practitioner-patient therapeutic relationship. In this way, nurses can help to limit the negative consequences of this common disorder and improve overall treatment outcomes in this population. . Thus this study will be conducted to assess the effectiveness of active self-administered acupressure on diarrhea-predominant irritable bowel syndrome

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with diarrhea irritable bowel syndrome symptoms following Rome IV diagnostic criteria
  • Agreed to be on a fixed dose of the pharmacological therapy throughout the study

Exclusion criteria

  • Patients with severe lesions in major organs such as the heart, liver, and kidney, hematopoietic diseases, or tumors
  • Eating disorders
  • History of major abdominal surgery
  • History of neurological and mental illness
  • Usage of other treatment rather than the medical treatment regularly 2 weeks before randomization and throughout the study
  • Previous history of drug or alcohol abuse 6 months before randomization
  • Pregnant and lactating women.
  • Patient reporting of adequate relief of their irritable bowel syndrome symptoms the week preceding the randomization
  • Patient has too mild symptoms ( obtaining less than 75 on Irritable bowel syndrome symptoms severity scale at the baseline assessment)
  • Currently participating in other clinical trials

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

70 participants in 2 patient groups

Active acupoints group
Experimental group
Description:
All participants in the active group will be treated with basic acupoints Zhongwan (CV 12), Tianshu (ST25) in alternation with Sanyinjiao (SP 6), Zusanli (ST 36). Moreover according to traditional Chinese medicine diagnosis, additional acupoints will be added. The frequency of acupressure treatment will be twice a day for 4 weeks, in total 56 sets.
Treatment:
Other: Active acupressure
Sham acupoints group
Sham Comparator group
Description:
All participants on the sham acupoints group will recieive sham Zhongwan (CV 12), sham Tianshu (ST25), sham Sanyinjiao (SP 6), and sham Zusanli (ST 36) acupressure. All the sham points are 2 cm outside and parallel to the actual points which do not match any recognized acupuncture points and are thought to have no therapeutic effect. The frequency of acupressure treatment will be twice a day for 4 weeks, in total 56 sets.
Treatment:
Other: Sham acuptressure

Trial contacts and locations

1

Loading...

Central trial contact

Maha G Asal, Phd; Zahra H Ramzy, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems